Cover Image
市場調查報告書

先天性腎上腺皮質增生症 (腎上腺性徵異常症候群) :全球臨床實驗趨勢

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 345356
出版日期 內容資訊 英文 45 Pages
訂單完成後即時交付
價格
Back to Top
先天性腎上腺皮質增生症 (腎上腺性徵異常症候群) :全球臨床實驗趨勢 Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Global Clinical Trials Review, H2, 2015
出版日期: 2015年10月21日 內容資訊: 英文 45 Pages
簡介

本報告提供先天性腎上腺皮質增生症 (腎上腺性徵異常症候群) 臨床實驗相關之最新趨勢分析,提供您各地區主要國家的臨床實驗數量,臨床實驗的各階段進展,實驗對象採用狀況,有潛力的贊助商,並彙整各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:荷爾蒙障礙治療藥臨床實驗的先天性腎上腺皮質增生症 (腎上腺性徵異常症候群) 所佔比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:荷爾蒙障礙治療藥臨床實驗的先天性腎上腺皮質增生症 (腎上腺性徵異常症候群) 所佔比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

先天性腎上腺皮質增生症 (腎上腺性徵異常症候群) 治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介概要

附錄

目錄
Product Code: GDHC2914CTIDB

GlobalData's clinical trial report, "Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Global Clinical Trials Review, H2, 2015" provides an overview of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) clinical trials scenario. This report provides top line data relating to the clinical trials on Congenital Adrenal Hyperplasia (Adrenogenital Syndrome). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) to Hormonal Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) to Hormonal Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, Global, Clinical Trials by Region, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) to Hormonal Disorders Clinical Trials, G7 Countries (%), 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) to Hormonal Disorders Clinical Trials, E7 Countries (%), 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*

List of Figures

  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Proportion of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) to Hormonal Disorders Clinical Trials, G7 Countries (%), 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) to Hormonal Disorders Clinical Trials, E7 Countries (%), 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top